Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Heat Biologics Inc
(NY:
HTBX
)
N/A
UNCHANGED
Last Price
Updated: 8:00 PM EDT, May 2, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Heat Biologics Inc
Heat Biologics' Subsidiary Outlines Development of New Commercial/Biodefense Biomanufacturing Facility
April 18, 2022
Via
Benzinga
66 Biggest Movers From Yesterday
March 23, 2022
Gainers JX Luxventure Limited (NASDAQ: LLL) shares jumped 119.5% to settle at $4.39 on Tuesday after the company announced it signed a $60 million sales agreement. Forge Global...
Via
Benzinga
Heat Biologics' Merger Partner Elusys Finalizes HHS Contract For Its Anthrax Treatment
January 31, 2022
Elusys Therapeutics Inc, the merger partner for Heat Biologics Inc (NASDAQ: HTBX), has
Via
Benzinga
Heat Biologics Is Starting To Run Away From Support Toward Resistance
August 26, 2021
Heat Biologics Inc. (NASDAQ:HTBX) shares traded ...
Via
Benzinga
Heat Biologics Issues New PTX-35 Preclinical Data In Organ Transplantation, Update On HS-110
January 12, 2022
Heat Biologics Inc (NASDAQ: HTBX) announced promising preclinical data regarding PTX-35. The data has been accepted for publication in the American Journal of...
Via
Benzinga
Heat Biologics To Bolster Presence In Biodefense Space With Elusys Acquisition
December 21, 2021
Heat Biologics Inc (NASDAQ: HTBX) will acquire Elusys Therapeutics, a commercial-stage biodefense company and the manufacturer of Anthim (obiltoxaximab)...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 02, 2021
Gainers Innate Pharma (NASDAQ:IPHA) shares rose 18.22% to $4.28 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 20.8...
Via
Benzinga
46 Stocks Moving In Friday's Mid-Day Session
June 11, 2021
Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares jumped 73.3% to $15.67...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
64 Biggest Movers From Friday
June 14, 2021
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
12 Health Care Stocks Moving In Friday's Intraday Session
June 11, 2021
Gainers Novan (NASDAQ:NOVN) stock rose 71.04% to $15.46 during Friday's regular session. As of 12:30 EST, Novan's stock is trading at a volume of 109.3 million,...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 11, 2021
Gainers GBS (NASDAQ:GBS) stock increased by 41.04% to $5.12 during Friday's pre-market session. Novan (NASDAQ:NOVN) stock increased by 36.5% to $12.34. The company...
Via
Benzinga
28 Stocks Moving in Friday's Pre-Market Session
June 11, 2021
Gainers Amesite Inc. (NASDAQ: AMST) rose 138% to $6.60 in pre-market trading after surging over 25% on Thursday. Chemomab Therapeutics Ltd. (NASDAQ: CMMB) rose 37.5% to $27.50...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
June 10, 2021
Gainers Tyme Technologies (NASDAQ:TYME) s...
Via
Benzinga
Heat Biologics Surges On Patent Filing
June 10, 2021
Heat Biologics Inc. (NASDAQ:HTBX) shares traded higher Thu...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
66 Biggest Movers From Yesterday
June 11, 2021
Gainers Orphazyme A/S (NASDAQ: ORPH) shares jumped 302.3% to close at $21.00 on Thursday. Shares of the biopharmaceutical firm touched an intraday high of $77.77, running up 1,...
Via
Benzinga
Heat Biologics' Lead Candidate Shows Overall Survival Benefit In Lung Cancer Study
May 20, 2021
Heat Biologics Inc (NASDAQ: HTBX) has reported interim data from the Phase 1/2 trial evaluating its lead product, HS-110, in combination with ...
Via
Benzinga
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
May 31, 2021
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 20, 2021
Gainers VistaGen Therapeutics (NASDAQ:VTGN) shares moved upwards by 14.34% to $2.63 during Thursday's pre-market session. The market value of their outstanding shares...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 19, 2021
Gainers Advaxis (NASDAQ:ADXS) shares increased by 27.34% to $0.62 during Wednesday's pre-market session. The company's market cap stands at $85.2 million. Lixte...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 12, 2021
Gainers Auris Medical Holding (NASDAQ:EARS) stock increased by 21.8% to $5.25 during Monday's pre-market session. The company's market cap stands at $67.5 million...
Via
Benzinga
Heat Biologics Announces New Preclinical Data on PTX-35, Demonstrating Decreased Regulatory T-cell (Treg) Activity and Delayed Tumor Progression at American Association for Cancer Research (AACR) Annual Meeting 2021
April 12, 2021
DURHAM, NC / ACCESSWIRE / April 12, 2021 / Heat Biologics, Inc. (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system,...
From
Heat Biologics, Inc.
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.